https://www.selleckchem.com/products/etc-159.html
146,p 0.02 with age being the strongest predictor (p 0.004). The same model explained 20.1% of the variance of duration of BoNT efficacy, showing a significant prediction of the outcome (F(11, 164) = 3.754,p 0.001), with doses (p 0.001), type of toxin (p 0.017), and clinical condition (p 0.001) being the strongest predictors. Our findings suggest that age, type of toxin, clinical condition and especially doses may account for the variability of BoNT efficacy in terms of time to onset and duration. Our findings suggest t
Gefällt mir
Kommentar
Teilen
